With continued investment and growing buzz from the industry, the AI hype is expected to extend through 2025 and beyond.

West Virginia University ( WVU ), one of the top public research institutions in the nation, has formed a strategic ...

Multi-Modal Models: A multi-modal discovery approach was implemented that engineered-in potency against the novel target and engineered-out a specific off-target interaction. The NCE library displayed ...

With the use of deep learning and advanced algorithms, generative AI can promote acceleration in the design and development ...

Functional genomics can help deconvolute the link between genotype and phenotype in disease, revealing new drug targets and ...

Target-guided synthesis (TGS) is an innovative approach in drug discovery that focuses on the direct interaction between a biological target and small molecule fragments. This method allows ...

The pharmaceutical industry is on the verge of a significant transformation due to the emergence of artificial intelligence ...

The AlphaMeld platform empowers key functional stakeholders, including those involved in early drug discovery, target identification, competitive intelligence, and clinical trial optimization. By ...

The global drug discovery services market is set for remarkable growth, with its valuation projected to surge from USD 19.7 ...

Insilico Medicine (“Insilico”), a clinical stage generative artificial intelligence (AI)-driven biotechnology company has ...

Cofounded by Dr. Siddhartha Mukherjee and Reid Hoffman, Manas AI leverages proprietary AI, generative computational chemistry ...